Check Cap Ltd is an Israel-based clinical-stage medical diagnostics company. Check Cap Ltd develops C-Scan, patient-friendly preparation-free test designed to detect polyps before they may transform into cancer to enable early intervention and cancer prevention. It's capsule-based screening technology aims to increase screening adherence worldwide. The system utilizes ultra-low-dose X- rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities. C-Scan is non-invasive capsule that is propelled through the gastrointestinal tract by natural motility. C-Scan is comprised of three main components: C-Scan Cap, an ingestible X-ray scanning capsule; C-Scan Track, three miniaturized patches worn on the patient’s back for integrated positioning, control and data recording; and C-Scan View, a proprietary software to process and represent 2D and 3D maps of the inner surface of the colon.
종목 코드 CHEK
회사 이름Check Cap Ltd
상장일Feb 19, 2015
CEOMr. Alex Ovadia
직원 수- -
유형Ordinary Share
회계 연도 종료Feb 19
주소29 Abba Hushi Ave.
도시
증권 거래소NASDAQ Capital Market Consolidated
국가Israel
우편 번호3009000
전화97248303401
웹사이트https://check-cap.com/
종목 코드 CHEK
상장일Feb 19, 2015
CEOMr. Alex Ovadia
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음